公司资料
Kenvue 股价、新闻与催化剂
- 股票代码:
- KVUE
- 交易所:
- NYSE
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
17.22 USD (-2.49%)
收盘价
最后更新: 2026年10月1日
33.3B USD
市值
股价为何变动
截至 2026年10月1日，KVUE 下跌 2.49%，收于 $17.22。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
Global Consumer Health Company
Kenvue is a pure-play consumer health company with a portfolio of self-care, skin health and beauty, and essential health brands. Its products are sold through pharmacies, mass merchants, grocery stores, e-commerce channels, and other retail outlets around the world.
Self Care Portfolio
The Self Care segment includes over-the-counter products for pain, allergy, digestive health, smoking cessation, and cough, cold, and flu. Major brands include Tylenol, Zyrtec, Pepcid, and Nicorette, supported by consumer marketing and healthcare-professional recognition.
Skin Health and Beauty
Skin Health and Beauty includes brands such as Neutrogena, Aveeno, and OGX. The business competes through dermatological positioning, product renovation, digital marketing, and new formulations across facial care, sun care, body care, and hair care.
Essential Health Brands
Essential Health covers oral care, wound care, baby care, and women's health. Listerine, Band-Aid, Johnson's, Stayfree, and related brands provide recurring demand across everyday categories and give Kenvue broad retail distribution.
Brand-Led Innovation Model
Kenvue combines established household brands with formulation, packaging, and claims innovation. Recent activity includes new Neutrogena and OGX products, Listerine formats, wound-care products, and an FDA-approved fixed-dose Tylenol and naproxen combination.
未来催化剂
- U.S. retail launch of Tylenol with Naproxen following FDA approval.
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。